Safety and Efficacy of Low-Dose Continuous Infusion of Landiolol, an Ultra-Short-Acting β-blocker, in Cardiac Surgery

Safety and Efficacy of Low-Dose Continuous Infusion of Landiolol, an Ultra-Short-Acting β-blocker, in Cardiac Surgery

Introduction: Landiolol hydrochloride is an ultra-short-acting β-blocker that is administered intravenously and has many advantages in cardiac surgery. This study was performed to examine the safety and efficacy of low-dose landiolol continuous infusion in cardiac surgery. Methods and Results: Ninet...

Full description

Bibliographic Details
Main Authors: Manabu Sato, MD, Etsuro Suenaga, MD, Hideyuki Fumoto, MD, Hiromitsu Kawasaki, MD, Shugo Koga, MD, Fumie Maki, MD
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Arrhythmia
Subjects:
Ultra-short-acting β-blocker
Landiolol
Hemodynamics
Supraventricular tachyarrythmia
Cardiac surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S1880427611800086

Internet

http://www.sciencedirect.com/science/article/pii/S1880427611800086

Similar Items